Deregulation of DNA double-strand break repair in multiple myeloma: implications for genome stability.

by Ana B Herrero, Jesús San Miguel, Norma C Gutierrez
Published 2015-01-01

Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple Myeloma

by Ana B. Herrero, Elizabeta A. Rojas, Irena Misiewicz-Krzeminska, Patryk Krzeminski, Norma C. Gutiérrez
Published 2016-11-01

Microtubule Destabilizing Sulfonamides as An Alternative to Taxane-Based Chemotherapy

by Myriam González, María Ovejero-Sánchez, Alba Vicente-Blázquez, Raquel Álvarez, Ana B. Herrero, Manuel Medarde, Rogelio González-Sarmiento, Rafael Peláez
Published 2021-02-01

DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma

by Dalia Quwaider, Luis A. Corchete, Irena Misiewicz-Krzeminska, María E. Sarasquete, José J. Pérez, Patryk Krzeminski, Noemí Puig, María Victoria Mateos, Ramón García-Sanz, Ana B. Herrero, Norma C. Gutiérrez
Published 2017-04-01

Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair

by Ana-Alicia López-Iglesias, Ana B. Herrero, Marta Chesi, Laura San-Segundo, Lorena González-Méndez, Susana Hernández-García, Irena Misiewicz-Krzeminska, Dalia Quwaider, Montserrat Martín-Sánchez, Daniel Primo, Teresa Paíno, P. Leif Bergsagel, Thomas Mehrling, Marcos González-Díaz, Jesús F. San-Miguel, María-Victoria Mateos, Norma C. Gutiérrez, Mercedes Garayoa, Enrique M. Ocio
Published 2017-06-01